mvjrМедицинский вестник Юга РоссииMedical Herald of the South of Russia2219-80752618-7876The Rostov State Medical University10.21886/2219-8075-2023-14-2-44-51mvjr-1742Research ArticleАКУШЕРСТВО И ГИНЕКОЛОГИЯOBSTETRICS AND GYNECOLOGYСовременные подходы к тактике ведения беременности при миоме маткиModern approaches to the management of pregnancy in uterine myomahttps://orcid.org/0000-0001-9673-9077ФаткуллинИ. Ф.FatkullinI. F.

Ильдар Фаридович Фаткуллин, д. м. н., профессор,заведующий кафедрой

кафедра акушерства и гинекологии им. проф. В. С. Груздева

Казань

Ildar F. Fatkullin, Dr. Sci. (Med.), professor, head ofDepartment

Department of Obstetrics and Gynecology named after Prof. V. S. Gruzdev

Kazan

fatkullin@yandex.ruhttps://orcid.org/0000-0002-3871-045XОрловЮ. В.OrlovY. V.

Юрий Валерьевич Орлов, к. м. н., руководитель центра, доцент

аккредитационно-симуляционный центр

кафедра акушерства и гинекологии им. проф. В. С. Груздева

Казань

Yuriy V. Orlov, PhD, head of the accreditation and simulation center, associate professor

accreditation and simulation center

Department of Obstetrics and Gynecology named after Prof. V. S. Gruzdev

Kazan

scenter@kazangmu.ruhttps://orcid.org/0000-0002-5806-9153ФаткуллинФ. И.FatkullinF. I.

Фарид Ильдарович Фаткуллин, к. м. н., заведующий отделением

акушерское отделение

Казань

Farid I. Fatkullin, PhD, head of the department

obstetric department

Kazan

ffatkullin@ya.ruКазанский государственный медицинский университетРоссияKazan State Medical UniversityRussian FederationГородская клиническая больница № 7РоссияKazan City Clinical Hospital No. 7Russian Federation2023260520231424451Copyright © Фаткуллин И.Ф., Орлов Ю.В., Фаткуллин Ф.И., 20232023Фаткуллин И.Ф., Орлов Ю.В., Фаткуллин Ф.И.Fatkullin I.F., Orlov Y.V., Fatkullin F.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medicalherald.ru/jour/article/view/1742

   В представленном обзоре обобщены современные данные о тактике сопровождения пациенток с миомой матки на различных этапах реализации их репродуктивного потенциала (стадии прегравидарной подготовки, этапа ведения беременности, момента родоразрешения и послеродового периода). На основе анализа отечественной и зарубежной специальной научно-практической литературы предлагаются различные методы ведения родов, от более предпочтительного родоразрешения через естественные родовые пути до необходимого кесарева сечения, произведённого строго по показаниям. Представлены данные о вариантах проведения плановой и экстренной миомэктомии при беременности, при оперативном родоразрешении и в послеродовом периоде. По итогам систематизации полученной информации авторами ставится вопрос о необходимости проведения дальнейших исследований в области разработки методов оптимального ведения пациенток в условиях беременности и родов, осложнённых миомой матки, ввиду актуальности обсуждаемых проблем.

   The presented review summarizes current data on the tactics of accompanying patients with uterine myoma at various stages of their reproductive potential realization: the stage of pregravid preparation, the stage of pregnancy management, the moment of delivery and the postpartum period. Based on the analysis of domestic and foreign special scientific and practical literature, various methods of childbirth are proposed, from more preferable delivery through the natural birth canal, to the necessary caesarean section, performed strictly according to indications. Data are presented on the options for elective and emergency myomectomy during pregnancy, during operative delivery and in the postpartum period. Based on the results of systematization of the information received, the authors raise the question of the need for further research in the field of developing methods for optimal management of patients during pregnancy and childbirth complicated by uterine myoma, due to the relevance of the problems discussed.

миома маткибеременность при миоме маткикесарево сечениемиомэктомияuterine myomapregnancy with uterine myomacaesarean sectionmyomectomyИсследование не имело спонсорской поддержкиThe study had no sponsorshipReferencesФаткуллин И. Ф., Баканова А. Р., Илизарова Н. А., Галеев А. А. Новые возможности лечения миомы матки у женщин при нарушении репродуктивной функции. Доктор.Ру. 2016; 8-9 (125-126): 32-37.Fatkullin I. F., Bakanova A. R., Ilizarova N. A., Galeev A. A. New possibilities of treatment of uterine fibroids in women with reproductive dysfunction. Doctor.Ru. 2016; 8-9 (125-126): 32-37. (In Russ.). eLIBRARY ID: 27656551.Chill H. H., Karavani G., Rachmani T., Dior U., Tadmor O., Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Womens Health. 2019; 19 (1): 100. doi: 10.1186/s12905-019-0803-5Chill H. H., Karavani G., Rachmani T., Dior U., Tadmor O., Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Womens Health. 2019; 19 (1): 100. doi: 10.1186/s12905-019-0803-5Pécout M., Cosson M., Collinet P., Rubod C., Giraudet G. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant. J Gynecol Obstet Hum Reprod. 2019; 48 (9): 781-783. doi: 10.1016/j.jogoh.2019.03.015Pécout M., Cosson M., Collinet P., Rubod C., Giraudet G. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant. J Gynecol Obstet Hum Reprod. 2019; 48 (9): 781-783. doi: 10.1016/j.jogoh.2019.03.015Baird D. D., Patchel S. A., Saldana T. M., Umbach D. M., Cooper T., et al. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am J Obstet Gynecol. 2020; 223 (3): 402.e1-402.e18. doi: 10.1016/j.ajog.2020.02.016Baird D. D., Patchel S. A., Saldana T. M., Umbach D. M., Cooper T., et al. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am J Obstet Gynecol. 2020; 223 (3): 402.e1-402.e18. doi: 10.1016/j.ajog.2020.02.016Sohn G. S., Cho S., Kim Y. M., Cho C. H., Kim M. R., et al. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018; 61 (2): 192-201. doi: 10.5468/ogs.2018.61.2.192Sohn G. S., Cho S., Kim Y. M., Cho C. H., Kim M. R., et al. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018; 61 (2): 192-201. doi: 10.5468/ogs.2018.61.2.192Giuliani E., As-Sanie S., Marsh E. E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020; 149 (1): 3-9. doi: 10.1002/ijgo.13102Giuliani E., As-Sanie S., Marsh E. E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020; 149 (1): 3-9. doi: 10.1002/ijgo.13102Orlando M., Kollikonda S., Hackett L., Kho R. Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review. J Minim Invasive Gynecol. 2021; 28 (3): 598-618.e1. doi: 10.1016/j.jmig.2020.10.006Orlando M., Kollikonda S., Hackett L., Kho R. Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review. J Minim Invasive Gynecol. 2021; 28 (3): 598-618.e1. doi: 10.1016/j.jmig.2020.10.006Cagan M., Tanacan A., Donmez H. G., Fadiloglu E., Unal C., Beksac M. S. The Effect of Small Size Uterine Fibroids on Pregnancy Outcomes in High-risk Pregnancies. Rev Bras Ginecol Obstet. 2020; 42 (9): 535-539. doi: 10.1055/s-0040-1713913Cagan M., Tanacan A., Donmez H. G., Fadiloglu E., Unal C., Beksac M. S. The Effect of Small Size Uterine Fibroids on Pregnancy Outcomes in High-risk Pregnancies. Rev Bras Ginecol Obstet. 2020; 42 (9): 535-539. doi: 10.1055/s-0040-1713913Sleiman Z., Baba R. E., Garzon S., Khazaka A. The Significant Risk Factors of Intra-Operative Hemorrhage during Laparoscopic Myomectomy: A Systematic Review. Gynecol Minim Invasive Ther. 2019; 9 (1): 6-12. doi: 10.4103/GMIT.GMIT_21_19Sleiman Z., Baba R. E., Garzon S., Khazaka A. The Significant Risk Factors of Intra-Operative Hemorrhage during Laparoscopic Myomectomy: A Systematic Review. Gynecol Minim Invasive Ther. 2019; 9 (1): 6-12. doi: 10.4103/GMIT.GMIT_21_19Sparic R., Dokić M., Likić-Lađević I., Vidakovic S. Is cesarean myomectomy in patients with large multiple myomas always a hazardous procedure? А case report (Running title: Cesarean myomectomy in the treatment of large multiple myomas). SJAIT. 2018; 7-8: 171-176. doi: 10.5937/sjait1806125RSparic R., Dokić M., Likić-Lađević I., Vidakovic S. Is cesarean myomectomy in patients with large multiple myomas always a hazardous procedure? А case report (Running title: Cesarean myomectomy in the treatment of large multiple myomas). SJAIT. 2018; 7-8: 171-176. doi: 10.5937/sjait1806125RHerrmann A., Torres-de la Roche L. A., Krentel H., Cezar C., de Wilde M. S., et al. Adhesions after Laparoscopic Myomectomy: Incidence, Risk Factors, Complications, and Prevention. Gynecol Minim Invasive Ther. 2020; 9 (4): 190-197. doi: 10.4103/GMIT.GMIT_87_20Herrmann A., Torres-de la Roche L. A., Krentel H., Cezar C., de Wilde M. S., et al. Adhesions after Laparoscopic Myomectomy: Incidence, Risk Factors, Complications, and Prevention. Gynecol Minim Invasive Ther. 2020; 9 (4): 190-197. doi: 10.4103/GMIT.GMIT_87_20Borghese G., Raffone A., Raimondo D., Saccone G., Travaglino A., et al. Adhesion barriers in laparoscopic myomectomy: Evidence from randomized clinical trials. Int J Gynaecol Obstet. 2021; 152 (3): 308-320. doi: 10.1002/ijgo.13495Borghese G., Raffone A., Raimondo D., Saccone G., Travaglino A., et al. Adhesion barriers in laparoscopic myomectomy: Evidence from randomized clinical trials. Int J Gynaecol Obstet. 2021; 152 (3): 308-320. doi: 10.1002/ijgo.13495Lasmar R. B., Lasmar B. P., Moawad N. S. Hysteroscopic myomectomy. Medicina. 2022; 58 (11): 1627. doi: 10.3390/medicina58111627Lasmar R. B., Lasmar B. P., Moawad N. S. Hysteroscopic myomectomy. Medicina. 2022; 58 (11): 1627. doi: 10.3390/medicina58111627Sankaran S. M., Pillai J. S. Fetomaternal outcome in fibroid complicating pregnancy: a retrospective study. Int J Reprod Contracept Obstet Gynecol. 2021; 10 (7): 2613-2619. doi: 10.18203/2320-1770.ijrcog20212330Sankaran S. M., Pillai J. S. Fetomaternal outcome in fibroid complicating pregnancy: a retrospective study. Int J Reprod Contracept Obstet Gynecol. 2021; 10 (7): 2613-2619. doi: 10.18203/2320-1770.ijrcog20212330Rezk A., Kahn J., Singh M. Fertility Sparing Management In Uterine Fibroids. 2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. PMID: 34662018.Rezk A., Kahn J., Singh M. Fertility Sparing Management In Uterine Fibroids. 2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. PMID: 34662018.Ludwig P. E., Huff T. J., Shanahan M. M., Stavas J.M. Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature. Br J Radiol. 2020; 93 (1105): 20190551. doi: 10.1259/bjr.20190551Ludwig P. E., Huff T. J., Shanahan M. M., Stavas J.M. Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature. Br J Radiol. 2020; 93 (1105): 20190551. doi: 10.1259/bjr.20190551Радзинский В. Е., Ордиянц И. М., Хорольский В. А. Лечение миомы: вариативность как проблема. StatusPraesens. 2015; 3: 38–45.Radzinskij V. E., Ordiyanc I. M., Horol'skij V. A. Myoma treatment: variability as a problem. StatusPraesens. 2015; 3: 38-45. (In Russ.). eLIBRARY ID: 29254496Шаповалова А. И. Лейомиома матки и репродукция. Журнал акушерства и женских болезней. 2019; 68 (1): 93-101.Shapovalova A. I. Uterine fibroid and reproduction. Journal of obstetrics and women's diseases. 2019; 68 (1): 93-101. (In Russ.) doi: 10.17816/JOwD68193-101Fernandez H. Acétate d’Ulipristal et SPRM : une nouvelle entité pour définir de nouvelles stratégies thérapeutiques pour les fibromes symptomatiques [Ulipristal acetate and SPRM: A new entity for the therapeutic strategy for symptomatic myomas]. Gynecol Obstet Fertil Senol. 2018; 46 (10-11): 671-672. (In French). Erratum in: Gynecol Obstet Fertil Senol. 2019; 47 (1): 90. doi: 10.1016/j.gofs.2018.09.003Fernandez H. Acétate d’Ulipristal et SPRM : une nouvelle entité pour définir de nouvelles stratégies thérapeutiques pour les fibromes symptomatiques [Ulipristal acetate and SPRM: A new entity for the therapeutic strategy for symptomatic myomas]. Gynecol Obstet Fertil Senol. 2018; 46 (10-11): 671-672. (In French). Erratum in: Gynecol Obstet Fertil Senol. 2019; 47 (1): 90. doi: 10.1016/j.gofs.2018.09.003Seth S., Goel N., Singh E., Mathur A. S., Gupta G. Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman. J Midlife Health. 2013; 4 (1): 22-6. doi: 10.4103/0976-7800.109630Seth S., Goel N., Singh E., Mathur A. S., Gupta G. Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman. J Midlife Health. 2013; 4 (1): 22-6. doi: 10.4103/0976-7800.109630Tîrnovanu M. C., Lozneanu L., Tîrnovanu Ş. D., Tîrnovanu V. G., Onofriescu M., et al. Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution. Healthcare (Basel). 2022; 10 (5): 855. doi: 10.3390/healthcare10050855Tîrnovanu M. C., Lozneanu L., Tîrnovanu Ş. D., Tîrnovanu V. G., Onofriescu M., et al. Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution. Healthcare (Basel). 2022; 10 (5): 855. doi: 10.3390/healthcare10050855Lee S. J., Ko H. S., Na S., Bae J. Y., Seong W. J., et al. Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study. BMC Pregnancy Childbirth. 2020; 20 (1): 716. doi: 10.1186/s12884-020-03406-9Lee S. J., Ko H. S., Na S., Bae J. Y., Seong W. J., et al. Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study. BMC Pregnancy Childbirth. 2020; 20 (1): 716. doi: 10.1186/s12884-020-03406-9Коротких И. Н., Лаптева Т. Н., Кураносова И. Ю. Анализ факторов риска, влияющих на осложненное течение беременности и исходы родов у женщин с миомой матки. Системный анализ и управление в биомедицинских системах. 2019; 18 (1): 40-44.Korotkih I. N., Lapteva T. N., Kuranosova I. Yu. Analysis of risk factors affecting the complicated course of pregnancy and birth outcomes in women with uterine myoma. System analysis and management in biomedical systems. 2019; 18 (1): 40-44. (In Russ.) doi: 10.25987/VSTU.2019.18.1.006American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008; 112 (2 Pt 1): 387-400. doi: 10.1097/AOG.0b013e318183fbabAmerican College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008; 112 (2 Pt 1): 387-400. doi: 10.1097/AOG.0b013e318183fbabPractice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017; 108 (3): 416-425. doi: 10.1016/j.fertnstert.2017.06.034Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017; 108 (3): 416-425. doi: 10.1016/j.fertnstert.2017.06.034Milazzo G. N., Catalano A., Badia V., Mallozzi M., Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017; 43 (12): 1789-1804. doi: 10.1111/jog.13437Milazzo G. N., Catalano A., Badia V., Mallozzi M., Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017; 43 (12): 1789-1804. doi: 10.1111/jog.13437Krimou Y., Erraghay S., Guennoun A., Mamouni N., Bouchikhi C., Banani A. Myoma praevia and pregnancy. Pan Afr Med J. 2019; 33: 216. doi: 10.11604/pamj.2019.33.216.14898Krimou Y., Erraghay S., Guennoun A., Mamouni N., Bouchikhi C., Banani A. Myoma praevia and pregnancy. Pan Afr Med J. 2019; 33: 216. doi: 10.11604/pamj.2019.33.216.14898Abdullah R. K, Massey I. Y., Liu N., Zhao Y., Zeng H. The differences in characteristics of uterine leiomyomas and the diverse adverse pregnancy outcomes. J Obstet Gynaecol. 2021; 41 (6): 841-847. doi: 10.1080/01443615.2020.1846020Abdullah R. K, Massey I. Y., Liu N., Zhao Y., Zeng H. The differences in characteristics of uterine leiomyomas and the diverse adverse pregnancy outcomes. J Obstet Gynaecol. 2021; 41 (6): 841-847. doi: 10.1080/01443615.2020.1846020Vitagliano A., Noventa M., Di Spiezio Sardo A., Saccone G., Gizzo S., et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch Gynecol Obstet. 2018; 297 (4): 823-835. doi: 10.1007/s00404-017-4621-4Vitagliano A., Noventa M., Di Spiezio Sardo A., Saccone G., Gizzo S., et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch Gynecol Obstet. 2018; 297 (4): 823-835. doi: 10.1007/s00404-017-4621-4Амангелды Л. Б., Рымжанова А. З., Койшыбаева Н. С. Миома матки и беременность. Евразийское Научное Объединение. 2021; (2-3): 141-142.Amangeldy L. B., Rymzhanova A. Z., Kojshybaeva N. S. Uterine myoma and pregnancy. Eurasian Scientific Association. 2021; 2-3: 141-142. (In Russ.) eLIBRARY ID: 44886126Кулаков В. И., Шмаков Г. С. Миомэктомия и беременность. М.: Медпрессинформ; 2001.Kulakov V. I., Shmakov G. S. Miomjektomija i beremennost'. Moskva: Medpressinform; 2001. (In Russ.).Parazzini F., Gerli S., Bianchi S., Chiaffarino F., Favilli A. Fibroids and Pregnancy. The Continuous Textbook of Women’s Medicine Series – Obstetrics Module. Vol. 6. Publisher: Global Library of women's Medicine's; 2021. doi: 10.3843/GLOwM.415733Parazzini F., Gerli S., Bianchi S., Chiaffarino F., Favilli A. Fibroids and Pregnancy. The Continuous Textbook of Women’s Medicine Series – Obstetrics Module. Vol. 6. Publisher: Global Library of women's Medicine's; 2021. doi: 10.3843/GLOwM.415733Доброхотова Ю. Э., Данелян С. Ж., Боровкова Е. И., Нагайцева Е. А., Сарахова Д. Х. и др. Специфика ведения беременности у пациенток с миомой матки. Клинический случай. Гинекология. 2021; 23 (2): 448–453.Dobrokhotova Iu. E., Danelian S. Zh., Borovkova E. I., Nagaitseva E. A., Sarakhova D. Kh., et al. Pregnancy management in patients with uterine fibroids. Case report. Gynecology. 2021; 23 (2): 448–453. (In Russ.) doi: 10.26442/20795696.2021.5.200777Буянова С. Н., Юдина Н. В., Гукасян С. А., Ермолаева Е. Е. Показания к миомэктомии во время беременности и ее исходы. Акушерство и Гинекология. 2019; 6: 70-77.Buyanova S. N., Yudina N. V., Gukasyan S. A., Ermolaeva E. E. Indications for myomectomy during pregnancy and outcomes. Obstetrics and Gynecology. 2019; 6: 70-7. (In Russ.). doi: 10.18565/aig.2019.6.70-77Баринов С. В., Чуловский Ю. И., Мозговой С. И., Шамина И. В., Ледовских И. О., Фрикель Е. А. Опыт ведения беременных во II триместре с миомой матки больших размеров. Российский вестник акушера-гинеколога. 2020; 20 (5): 54- 60.Barinov S. V., Chulovsky Yu. I., Mozgovoy S. I., Shamina I. V., Ledovskikh I. O., Frikel E. A. Experience in managing pregnant women in the second trimester with large uterine fibroids. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20 (5): 54-60. (In Russ.) doi: 10.17116/rosakush20202005154Тимохина Е. В., Губанова Е. В., Силаева Т. М. Беременность с миомой матки и после миомэктомии: результаты когортного исследования. Архив акушерства и гинекологии им. В. Ф. Снегирева. 2019; 6 (3): 132-139.Timokhina E. V., Gubanova E. V., Silayeva T. M. Pregnancy with uterine myoma and after myomectomy: results of the cohort study. V. F. Snegirev Archives of Obstetrics and Gynecology. 2019; 6 (3): 132-139. (In Russ.) doi: 10.18821/2313-8726-2019-6-3-132-139Кухарчик Ю. В., Гутикова Л. В., Колесникова Т. А. Течение беременности и родов у женщин с миомой матки. В: Современные перинатальные медицинские технологии в решении проблем демографической безопасности : сборник научных трудов. Минск: Республиканская научная медицинская библиотека; 2017.Kuharchik Ju. V., Gutikova L. V., Kolesnikova T. A. Techenie beremennosti i rodov u zhenshhin s miomoj matki. In: Sovremennye perinatal'nye medicinskie tehnologii v reshenii problem demograficheskoj bezopasnosti : sbornik nauchnyh trudov. Minsk: Respublikanskaja nauchnaja medicinskaja biblioteka; 2017. (In Russ.). eLIBRARY ID: 44035197Bofill Rodriguez M., Lethaby A., Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019; 9 (9): CD000400. doi: 10.1002/14651858.CD000400.pub4Bofill Rodriguez M., Lethaby A., Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019; 9 (9): CD000400. doi: 10.1002/14651858.CD000400.pub4Claeys J., Hellendoorn I., Hamerlynck T., Bosteels J,. Weyers S. The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis. Gynecol Surg. 2014; 11: 197–206. DOI: 10.1007/s10397-014-0842-8Claeys J., Hellendoorn I., Hamerlynck T., Bosteels J,. Weyers S. The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis. Gynecol Surg. 2014; 11: 197–206. DOI: 10.1007/s10397-014-0842-8Роды одноплодные, родоразрешение путем кесарева сечения. Клинические рекомендации. М.; 2020. Ссылка активна на 16. 03. 2023.Rody odnoplodnye, rodorazreshenie putem kesareva sechenija. Klinicheskie rekomendacii. Moskva; 2020. Accessed March 16. 2023. http://minzdravrm.ru/wp-content/uploads/2021/07/Rodi_odnoplodtii_rodorazrechenie_putem_kesareva.pdfGoyal M., Dawood A. S., Elbohoty S. B., Abbas A. M., Singh P., et al. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021; 256: 145-157. doi: 10.1016/j.ejogrb.2020.11.008Goyal M., Dawood A. S., Elbohoty S. B., Abbas A. M., Singh P., et al. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021; 256: 145-157. doi: 10.1016/j.ejogrb.2020.11.008Huang Y., Ming X., Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022; 35 (13): 2619-2627. doi: 10.1080/14767058.2020.1791816Huang Y., Ming X., Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022; 35 (13): 2619-2627. doi: 10.1080/14767058.2020.1791816Sei K., Masui K,. Sasa H., Furuya K. Size of uterine leiomyoma is a predictor for massive haemorrhage during caesarean delivery. Eur J Obstet Gynecol Reprod Biol. 2018; 223: 60-63. doi: 10.1016/j.ejogrb.2018.02.014Sei K., Masui K,. Sasa H., Furuya K. Size of uterine leiomyoma is a predictor for massive haemorrhage during caesarean delivery. Eur J Obstet Gynecol Reprod Biol. 2018; 223: 60-63. doi: 10.1016/j.ejogrb.2018.02.014Delli Carpini G., Morini S., Papiccio M., Serri M., Damiani V., et al. The association between childbirth, breastfeeding, and uterine fibroids: an observational study. Sci Rep. 2019; 9 (1): 10117. doi: 10.1038/s41598-019-46513-0Delli Carpini G., Morini S., Papiccio M., Serri M., Damiani V., et al. The association between childbirth, breastfeeding, and uterine fibroids: an observational study. Sci Rep. 2019; 9 (1): 10117. doi: 10.1038/s41598-019-46513-0Yang Q., Ciebiera M., Bariani M. V., Ali M., Elkafas H., et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022; 43 (4): 678-719. doi: 10.1210/endrev/bnab039.Yang Q., Ciebiera M., Bariani M. V., Ali M., Elkafas H., et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022; 43 (4): 678-719. doi: 10.1210/endrev/bnab039.Datir S. G., Bhake A. Management of Uterine Fibroids and Its Complications During Pregnancy: A Review of Literature. Cureus. 2022; 14 (11): e31080. DOI: 10.7759/cureus.31080Datir S. G., Bhake A. Management of Uterine Fibroids and Its Complications During Pregnancy: A Review of Literature. Cureus. 2022; 14 (11): e31080. DOI: 10.7759/cureus.31080Coutinho L. M., Assis W. A., Spagnuolo-Souza A., Reis F. M. Uterine Fibroids and Pregnancy: How Do They Affect Each Other? Reprod Sci. 2022; 29 (8): 2145-2151. doi: 10.1007/s43032-021-00656-6Coutinho L. M., Assis W. A., Spagnuolo-Souza A., Reis F. M. Uterine Fibroids and Pregnancy: How Do They Affect Each Other? Reprod Sci. 2022; 29 (8): 2145-2151. doi: 10.1007/s43032-021-00656-6

The authors declare that there are no conflicts of interest present.